MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment

Metadherin (MTDH) is identified as an oncogene in multiple cancers including breast cancer, bladder cancer and endometrial cancer. However, the function of MTDH in multiple myeloma (MM) is still unexplored. In this study, we disclose that MTDH is an oncogene in MM. This is characterized by an elevat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Chunyan, Feng, Lang, Peng, Hailin, Yang, Hongbao, Feng, Zhenqing, Yang, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826226/
https://www.ncbi.nlm.nih.gov/pubmed/26683226
http://dx.doi.org/10.18632/oncotarget.6610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826226/
https://www.ncbi.nlm.nih.gov/pubmed/26683226
http://dx.doi.org/10.18632/oncotarget.6610

Ejemplares similares